Literature DB >> 28825253

[Reducing the number of orders for coagulation tests in the standard emergency department blood work-up].

José María Ferreras Amez1, Marco Antonio Sarrat Torres1, Belén Arribas Entrala2, Vicente Carrasco Baraja3, Ángeles Pérez Layo3, Jóse Miguel Franco Sorolla4.   

Abstract

OBJECTIVES: To evaluate the usefulness of a clinical protocol developed to reduce the number of orders for coagulation tests.
MATERIAL AND METHODS: Quasi-experimental study with historical controls. We retrospectively included all patients whose records showed that a coagulation test had been ordered in the emergency department. We analyzed the number of tests ordered under the protocol and the number ordered during the period of standard practice.
RESULTS: Orders for coagulation tests were given for 657 patients (77.2%) when physicians followed standard practices and for 448 (55.5%) when they followed the protocol (P <.001). Unnecessary tests numbered 431 (65.6%) and 227 (50.6%) in the standard-practice and protocol periods, respectively (P <.002). One patient (0.15% [95% CI, 0.004%-0.8%]) had significantly altered coagulation (international normalized ratio, 1.8), but none (0% [95% CI, 0%-0.6%]) required treatment and no treatment plans were changed based on a finding of unexpected coagulation disorder.
CONCLUSION: The protocol to guide the ordering of coagulation tests has managed to reduce unnecessary tests and thus improve management of this health service resource.

Entities:  

Keywords:  Blood coagulation tests; Clinical protocols; Emergency health services; Protocolos clínicos; Pruebas de coagulación sanguínea; Servicios Médicos de Urgencias

Mesh:

Year:  2017        PMID: 28825253

Source DB:  PubMed          Journal:  Emergencias        ISSN: 1137-6821            Impact factor:   3.881


  1 in total

1.  Preanalytical errors in emergency department samples: Investigating error sources.

Authors:  Adolfo Romero; Juan Gómez-Salgado; Adolfo Romero-Arana; José Antonio Gómez-Fernández; Andrés Cobos; María Carmen Ramos; María Rosa Iglesias
Journal:  J Med Biochem       Date:  2020-10-02       Impact factor: 3.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.